Lastly, we utilized a K-M plotter based on the E-TABM-346 dataset (Figure 1H,I) and Zhuzhou Central Hospital’s (ZCH) DLBCL cohort (Figure 1J) to show that DLBCL patients with increased RPLP2 expression had worse outcomes regarding overall survival (OS). Here, RPLP2 is linked to diffuse large B-cell lymphoma.